Defunct Company
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
122
NCT07190144
Coronary Flow Reserve Changes After Semaglutide Treatment
Phase: N/A
Role: Collaborator
Start: Jan 7, 2025
Completion: Aug 1, 2025